Please provide your email address to receive an email when new articles are posted on . There are several patient factors that influence whether the speed of titration should be slower or faster.

Please provide your email address to receive an email when new articles are posted on . Use of oral add-on selexipag in children was well tolerated, safe and improved pulmonary arterial hypertension ...

This new data represents the first real-world, US-based data on this drug, demonstrating the efficacy and the safety indications of these clinical trials. Individuals with pulmonary arterial ...

A series of 5 cases highlights different opportunities to incorporate selexipag into the care of patients with pulmonary arterial hypertension, potentially eliminating risks associated with parenteral ...